ONC
BeOne Medicines Ltd
192 hedge funds and large institutions have $6.65B invested in BeOne Medicines Ltd in 2018 Q4 according to their latest regulatory filings, with 82 funds opening new positions, 65 increasing their positions, 30 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
33% more funds holding
Funds holding: 144 → 192 (+48)
0.23% more ownership
Funds ownership: 5.95% → 6.18% (+0.23%)
15% less capital invested
Capital invested by funds: $7.84B → $6.65B (-$1.19B)
Holders
192
Holding in Top 10
14
Calls
$50.8M
Puts
$21.1M
Top Buyers
| 1 | +$197M | |
| 2 | +$144M | |
| 3 | +$79.1M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$72.8M |
| 5 |
CGT
Capital Guardian Trust
Los Angeles,
California
|
+$47.5M |
Top Sellers
| 1 | -$622M | |
| 2 | -$368M | |
| 3 | -$315M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$47M |
| 5 |
Renaissance Technologies
New York
|
-$24.5M |